Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹3,272.50
Market cap: ₹26,792 Cr
Revenue (annual): ₹1,339 Cr
Net profit (annual): ₹356.3 Cr
P/E (TTM): 69.4×Sector 50.4×
Promoter holding: 32.66%+0.00% QoQ
FII holding: 21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Patent 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Capacity Expansion 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Jul 2026 18:21 IST BSE

Earnings Call

Acutaas Chemicals Earnings Call Transcript: Key Takeaways

Acutaas Chemicals delivered a robust Q1 FY27 with 59.1% revenue growth, fueled by strong CDMO and Advanced Pharmaceutical Intermediates (API) performance.

Call: Guides 25% growth

Open call summary → Read the filing ↗

24 Jul 2026 13:05 IST BSE

Earnings Call

Acutaas Chemicals Investor Presentation: Key Takeaways

Acutaas Chemicals delivered strong Q1 FY27 results with 59% YoY revenue growth. Management is focused on scaling high-margin Pharma Intermediates and CDMO segments while maintaining operational efficiencies.

Call: Guides 25% growth

Open call summary → Read the filing ↗